SARS-CoV-2 Mpro-IN-9

Overview

SARS-CoV-2 Mpro-IN-9 (compound c7) is a nonpeptidic, noncovalent SARS-CoV-2 M pro inhibitor ( IC 50 =0.085 μM), with improved physicochemical and drug metabolism and pharmacokinetics (DMPK) properties. SARS-CoV-2 Mpro-IN-9 inhibits viral replication ( EC 50 =1.10 μM) in SARS-CoV-2-infected Vero E6 cells, while exhibits low cytotoxic effects ( CC 50 >50 μM).

Application

Products | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > SARS-CoV

Product Information

• Catalog No.: HY-155527
• CAS No.: 2754370-99-3
• Molecular Formula: C20H14N2O4
• Molecular Weight: 346.34
• Purity: 99.31%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source